Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: IRMD

IRadimed Corporation

Healthcare | Medical - Devices

No licensed closing price on file for IRMD. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$1.79

IRadimed Corporation (NASDAQ: IRMD) is a medical device company. Figures from SEC EDGAR; updated 2026-10-20 11:27 UTC.

What IRadimed Corporation does

IRadimed develops, manufactures, and distributes medical devices designed to operate safely during MRI procedures, where standard equipment can malfunction due to magnetic interference. The company's primary products are the MRidium 3870 and MRidium 3860+ MRI-compatible IV infusion pump systems, which use non-magnetic components to safely deliver medications during MRI scans, and the IRadimed 3880 patient vital signs monitoring system that tracks critical measurements in the MRI environment.

Summarized from IRadimed Corporation’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$1.79
Return on equity23.76%

Revenue, margins & earnings

FY2021 Net income: $9MFY2021 Operating expenses: $22MFY2021 Cost of revenue: $10M$42MFY2021FY2022 Net income: $13MFY2022 Taxes & interest: $3MFY2022 Operating expenses: $26MFY2022 Cost of revenue: $12M$53MFY2022FY2023 Net income: $17MFY2023 Taxes & interest: $3MFY2023 Operating expenses: $30MFY2023 Cost of revenue: $15M$66MFY2023FY2024 Net income: $19MFY2024 Taxes & interest: $3MFY2024 Operating expenses: $34MFY2024 Cost of revenue: $17M$73MFY2024FY2025 Net income: $22MFY2025 Taxes & interest: $4MFY2025 Operating expenses: $38MFY2025 Cost of revenue: $19M$84MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-25
  • 2026-09-25DirectorRestricted Stock UnitsOption exercise-698—
  • 2026-09-25DirectorOption exercise698—
  • 2026-09-08DirectorSale-1,014$87.7K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does IRadimed Corporation do?

IRadimed develops, manufactures, and distributes medical devices designed to operate safely during MRI procedures, where standard equipment can malfunction due to magnetic interference.

When did IRMD last file with the SEC?

IRadimed Corporation's most recent SEC filing on record is a 8-K filed 2026-06-24. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 11:27 UTC. This page is also available as JSON at /api/data?ticker=IRMD and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for IRMD and 5,000+ tickers.

Create a free account — keep IRMD
For your agent
GET /api/data?ticker=IRMD

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt